Records containing: Idiopathic Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-23Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation
-
CLINICAL_TRIALS study record update · 2025-06-19A Phase 3, Open-Label Study of the Safety, Efficacy and Tolerability of Apomorphine Administered by Continuous Subcutaneous Infusion in Advanced Parkinson's Disease Patients With Unsatisfactory Control on Available Therapy
-
CLINICAL_TRIALS study record update · 2024-11-21A Phase I Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Autologous MitoCell (Adipose-Derived Mesenchymal Stem Cells) Transplantation in Subjects With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-09-03Comparison of Balance, Activity-specific Balance Confidence and Quality of Life in Parkinson's Patients with Freezing and Relationship Between Neutrophil/lymphocyte Ratio
-
CLINICAL_TRIALS study record update · 2024-04-10Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-04-10Use of a Robot for the Rehabilitation of Walking in Patients With Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2023-11-18Dopamine Effect on Inhibitory Control
-
CLINICAL_TRIALS study record update · 2023-04-04The Relationship of Neutrophil/Lymphocyte Ratio With Fatigue, Sleep and Quality of Life in Parkinson's Patients
-
CLINICAL_TRIALS study record update · 2023-02-17Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-10-12Physical Activity Behavior and Health-Related Quality of Life in Parkinson's Disease Patients: Role of Social Cognitive Variables
-
CLINICAL_TRIALS study record update · 2022-03-21An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
-
CLINICAL_TRIALS study record update · 2022-02-22Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing
-
CLINICAL_TRIALS study record update · 2021-10-21The Acute Effect of Cervical Mobilization on Balance and Gait in Patients With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2021-10-21The Acute Effect of Lumbo-sacral Mobilization on Functional Activities, Balance and Gait in Patients With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2020-11-20A Phase 3, 12-week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study to Evaluate the Efficacy of Oral Istradefylline 20 and 40 mg/Day as Treatment for Subjects With Moderate to Severe Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2020-03-26A Phase 1/2 Trial Assessing the Safety and Efficacy of Bilateral Intraputaminal and Intranigral Administration of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) in Subjects With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2019-12-13A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2019-10-29An Open-Label Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2019-10-29A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Compare IPX054 200 mg and 250 mg to CD-LD IR 200 (2x100) mg Tablets and CD-LD CR 200 mg Tablet in Subjects With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2019-07-30A 12 Month, Dose-Level Blinded Study Investigating the Safety and Efficacy of CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)
-
CLINICAL_TRIALS study record update · 2019-04-16Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2019-03-26A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
-
CLINICAL_TRIALS study record update · 2018-08-27Awake & Move. Role of Nocturnal Sleep and Rapid Eye Movement Sleep at Morning Awakening on Sleep Benefit in Parkinson's Disease. An Interventional Cross-over Study.
-
CLINICAL_TRIALS study record update · 2018-08-08A Phase 2b, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Inhaled CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)
-
CLINICAL_TRIALS study record update · 2018-07-10A Phase 3, Randomized Study Investigating the Safety of CVT-301 (Levodopa Inhalation Powder) in Parkinson's Disease (PD) Patients With Motor Response Fluctuations (OFF Phenomena) Compared to an Observational Cohort Control